Menagé H D, Norris P G, Hawk J L, Graves M W
St John's Institute of Dermatology, St Thomas' Hospital, London, U.K.
Br J Dermatol. 1993 Aug;129(2):163-5. doi: 10.1111/j.1365-2133.1993.tb03520.x.
Psoralen photochemotherapy (PUVA) was effective in the treatment of five patients with aquagenic pruritus, associated in one with polycythaemia rubra vera and in another with the myelodysplastic syndrome. Relapse occurred within 2-24 weeks when treatment was discontinued. Maintenance therapy or a further course of PUVA was necessary to maintain remission. This requirement may limit the value of the therapy.
补骨脂素光化学疗法（PUVA）对5例水源性瘙痒症患者有效，其中1例伴有真性红细胞增多症，另1例伴有骨髓增生异常综合征。停止治疗后，2至24周内复发。需要维持治疗或再次进行PUVA疗程以维持缓解状态。这一需求可能会限制该疗法的价值。
